🇺🇸 FDA
Patent

US 10426746

Methods of treating developmental disorders with biguanides

granted A61KA61K31/155A61P

Quick answer

US patent 10426746 (Methods of treating developmental disorders with biguanides) held by OVID THERAPEUTICS INC. expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OVID THERAPEUTICS INC.
Grant date
Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/155, A61P, A61P25/08, A61P25/14